Umang Alkesh Gosalia
About Umang Alkesh Gosalia
Data last updated:
Umang Alkesh Gosalia is a Managing Director at Parmax Pharma Limited (since 2016) and Director at Malwin Pharma Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹28.25 Cr; the largest is Parmax Pharma Limited at ₹28.24 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parmax Pharma Limited L24231GJ1994PLC023504 | Managing Director | 02 Jan 2016 | 1994 | ₹28.24 Cr (FY 2025) | Active |
 Malwin Pharma Private Limited U24231GJ2004PTC043664 | Director | 01 Sep 2021 | 2004 | ₹16,206 (FY 2024) | Active |
Board colleagues of Umang Alkesh Gosalia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ami Shah Rajeshbhai | 08158605 | Parmax Pharma Limited | Director |
| Bhakti Rameshbhai Aghera | Parmax Pharma Limited | Company Secretary | |
| Keyur Dineshbhai Vora | Parmax Pharma Limited | Cfo | |
| Nikhil Sureshchandra Uchat | 08427983 | Parmax Pharma Limited | Director |
| Pradeep Ramniklal Gosalia | 01130646 | Parmax Pharma Limited , Malwin Pharma Private Limited | Director |
| Salma Badrudin Thobhani | 11616267 | Parmax Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umang Alkesh Gosalia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umang Alkesh Gosalia
Umang Alkesh Gosalia currently holds 2 directorships: Parmax Pharma Limited (Managing Director, since 02 Jan 2016, revenue ₹28.24 Cr (FY 2025)); Malwin Pharma Private Limited (Director, since 01 Sep 2021, revenue ₹16,206 (FY 2024)).
Umang Alkesh Gosalia was first appointed on 02 Jan 2016 as Managing Director at Parmax Pharma Limited. The most recent appointment on record is 01 Sep 2021 at Malwin Pharma Private Limited.
The 2 current companies of Umang Alkesh Gosalia that report revenue have a combined latest revenue of ₹28.25 Cr: Parmax Pharma Limited ₹28.24 Cr (FY 2025); Malwin Pharma Private Limited ₹16,206 (FY 2024).
The current boards of Umang Alkesh Gosalia's companies include Ami Shah Rajeshbhai (Parmax Pharma Limited), Bhakti Rameshbhai Aghera (Parmax Pharma Limited), Keyur Dineshbhai Vora (Parmax Pharma Limited), Nikhil Sureshchandra Uchat (Parmax Pharma Limited), Pradeep Ramniklal Gosalia (Parmax Pharma Limited), Salma Badrudin Thobhani (Parmax Pharma Limited).